Biological Products, (No Diagnostic Substances)·BOSTON, MA
Financials
20 shown
Type
Period
Ended
Filed
10-K
FY 2025
12/31/25
3/5/26
→
10-Q
Q3 2025
9/30/25
11/5/25
→
10-Q
Q2 2025
6/30/25
8/11/25
→
10-Q
Q1 2025
3/31/25
5/8/25
→
10-K
FY 2024
12/31/24
2/27/25
→
10-Q
Q3 2024
9/30/24
11/12/24
→
↓
Earnings Releases (8-K)
16 shown
Filed
Period
3/5/26
Q1 FY2026
→
1/6/26
Q4 FY2026
→
11/5/25
Q4 FY2025
→
8/11/25
Q3 FY2025
→
5/8/25
Q2 FY2025
→
2/27/25
Q1 FY2025
→
↓
News (8-K)
35 shown
Filed
Type
Description
8/13/25
Agreement
Entry into a Material Definitive Agreement
→
6/12/25
Vote
Submission of Matters to a Vote of Security Holders
→
4/1/25
Reg FD
Regulation FD Disclosure
→
12/10/24
Exec Change
Departure or Appointment of Directors or Certain Officers
→
6/17/24
Vote
Submission of Matters to a Vote of Security Holders
→
5/28/24
Exec Change
Departure or Appointment of Directors or Certain Officers
→
↓
Prospectuses & Registrations
25 shown
Filed
Form
Description
12/30/25
S-3
S-3
→
8/13/25
424B5
424B5
→
8/12/25
424B5
424B5
→
4/29/25
ARS
FORM ARS
→
3/27/25
S-8
S-8
→
8/30/24
S-3
S-3
→
↓
Filing History(335 filings)
TypeDateAccessionPeriodSize
10-K
Mar 5, 2026
0001171843-26-001337FORM 10-K
Dec 31, 2025
8.9 MB
8-K
Mar 5, 2026
0001171843-26-001336FORM 8-K
Mar 5, 2026
269.1 KB
SCHEDULE 13G/A
Feb 13, 2026
0001193125-26-051513
—
18.8 KB
4
Feb 10, 2026
0001171843-26-000722
Feb 8, 2026
5.9 KB
SCHEDULE 13G
Jan 21, 2026
0002012383-26-000660
—
10.5 KB
4
Jan 12, 2026
0001171843-26-000205
Jan 9, 2026
5.9 KB
EFFECT
Jan 7, 2026
9999999995-26-000102
—
1.8 KB
8-K
Jan 6, 2026
0001171843-26-000083FORM 8-K
Jan 6, 2026
226.6 KB
4
Jan 5, 2026
0001171843-26-000062
Jan 2, 2026
7.8 KB
4
Jan 5, 2026
0001171843-26-000061
Jan 2, 2026
5.8 KB
4
Jan 5, 2026
0001171843-26-000060
Jan 2, 2026
8.2 KB
4
Jan 5, 2026
0001171843-26-000059
Jan 2, 2026
5.7 KB
4
Jan 5, 2026
0001171843-26-000058
Jan 2, 2026
5.3 KB
4
Jan 5, 2026
0001171843-26-000057
Jan 2, 2026
5.3 KB
4
Jan 5, 2026
0001171843-26-000056
Jan 2, 2026
7.6 KB
4
Jan 5, 2026
0001171843-26-000055
Jan 2, 2026
5.3 KB
4
Jan 5, 2026
0001171843-26-000054
Jan 2, 2026
5.8 KB
4
Jan 5, 2026
0001171843-26-000053
Jan 2, 2026
5.8 KB
4
Jan 5, 2026
0001171843-26-000052
Jan 2, 2026
5.3 KB
4
Jan 5, 2026
0001171843-26-000051
Jan 2, 2026
7.6 KB
3
Jan 5, 2026
0001171843-26-000050
Jan 2, 2026
10.6 KB
3
Jan 5, 2026
0001171843-26-000049
Jan 2, 2026
9.9 KB
DEL AM
Dec 31, 2025
0001193125-25-338288DEL AM
—
16.2 KB
S-3
Dec 30, 2025
0001193125-25-337063S-3
—
1.1 MB
4
Nov 18, 2025
0001171843-25-007400
Nov 16, 2025
5.5 KB
25 filings shown
Compass Therapeutics, Inc. — SlamSEC
Proxies
10 shown
Filed
Form
Description
4/29/25
DEFA14A
FORM DEFA14A
→
4/29/25
DEF 14A
DEF 14A
→
5/29/24
DEFA14A
DEFINITIVE ADDITIONAL MATERIALS
→
4/29/24
DEFA14A
DEFA14A
→
4/29/24
DEF 14A
DEF 14A
→
4/27/23
DEFA14A
FORM DEFA14A
→
↓
Ownership
40 shown
Filed
Form
Description
2/10/26
4
4
→
1/12/26
4
4
→
1/5/26
4
4
→
1/5/26
4
4
→
1/5/26
4
4
→
1/5/26
4
4
→
↓
Other Filings
40 shown
Filed
Form
Description
2/13/26
SCHEDULE 13G/A
SCHEDULE 13G/A
→
1/21/26
SCHEDULE 13G
SCHEDULE 13G
→
1/7/26
EFFECT
EFFECT
→
12/31/25
DEL AM
DEL AM
→
11/14/25
SCHEDULE 13G
SCHEDULE 13G
→
11/14/25
SCHEDULE 13G/A
SCHEDULE 13G/A
→
↓
A compass is a device that shows the cardinal directions used for navigation and geographic orientation. It typically consists of a magnetized needle or another element, such as a compass card or compass rose, that pivots to align itself with magnetic north.